# China NMPA Drug Inspection - Jining Vasculitis Hospital - Yiqi Tongmai Capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/jining-vasculitis-hospital/95212222-2104-4ccf-9efc-128cdf428990/
Source feed: China

> China NMPA drug inspection for Jining Vasculitis Hospital published February 09, 2018. Drug: Yiqi Tongmai Capsules. The Shandong Provincial Food and Drug Administration announced on February 9, 2018, the findings of sampling inspections

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Shandong Provincial Food and Drug Administration Regarding 9 Batches of Medical Institution Preparations Failing Quality Inspections (2018, No. 2)
- Company Name: Jining Vasculitis Hospital
- Publication Date: 2018-02-09
- Drug Name: Yiqi Tongmai Capsules
- Inspection Finding: The quality does not meet the standard requirements. The non-compliant items are inspection and content determination.
- Action Taken: The relevant municipal food and drug administration bureaus have taken control measures such as sealing, seizing, and suspending sales of the substandard products, and have investigated and dealt with the medical institutions in accordance with relevant laws and regulations.
- Summary: The Shandong Provincial Food and Drug Administration announced on February 9, 2018, the findings of sampling inspections conducted by five drug testing institutions, including Zibo Municipal Institute for Food and Drug Control. These inspections, likely spanning late 2017 given the batch numbers, revealed nine batches of substandard medical institution preparations from eight different institutions.Key violations included contamination in products such as Lianqiao Baidu Pills from Zibo Municipal Traditional Chinese Medicine Hospital, Huangdan Yinchen Oral Solution from Zibo Municipal Maternal and Child Health Hospital, Buzhong Yishen Capsules from Weifang Weicheng Economic Development Zone Hospital, and Calamine Lotion from Jining Municipal Institute of Dermatology and Venereology. Additionally, products like Yiqi Tongmai Capsules from Jining Vascular Disease Hospital and Pingxiao Baoshi Pills from Tai'an Second Traditional Chinese Medicine Hospital were found to be of substandard quality.Operating under the oversight of the National Medical Products Administration (NMPA) framework, relevant municipal food and drug administrations have implemented immediate control measures. These include sealing, seizing, and suspending the sale of the non-compliant products. Further actions involve thorough investigations into the implicated medical institutions and the enforcement of relevant laws and regulations. The institutions are mandated to investigate root causes, develop and execute rectification plans, and eliminate all identified risks, while supervisory bodies will maintain strengthened daily oversight.

Company: https://www.globalkeysolutions.net/companies/jining-vasculitis-hospital/fd76102f-2678-4de4-b50f-5ada9515224e/